2,851
edits
Nicotinamide Mononucleotide (NMN): Difference between revisions
Nicotinamide Mononucleotide (NMN) (view source)
Revision as of 02:36, 18 December 2023
, 18 December 2023→Clinical Trials
| Line 439: | Line 439: | ||
* Adults with hypertension have cells lining blood vessels — endothelial cells — with elevated concentrations of the NAD+ consuming enzyme CD38, which partially explains their lower NAD+ levels. | * Adults with hypertension have cells lining blood vessels — endothelial cells — with elevated concentrations of the NAD+ consuming enzyme CD38, which partially explains their lower NAD+ levels. | ||
|- | |- | ||
|{{pmid text| | |{{pmid text|35479740}} | ||
| | | | ||
| | | | ||